Saltar al contenido
Acerca de fragancia
Acerca de IFRA
Últimas actualizaciones Todas las últimas actualizaciones
Iniciativas y posiciones Iniciativas y posiciones
  • IFRA
    Standards Library
    Biblioteca de normas IFRA

    Base de datos clasificable y consultable de todas las normas de la IFRA.

    Leer más
  • IFRA
    Transparency List
    Lista de transparencia de IFRA

    Todos los ingredientes de las fragancias se hacen públicos

    Leer más
IFRA Regiones Todas las regiones
Todas las publicaciones
Biblioteca de normas IFRA

EU Cosmetic Products Regulation (CPR)

Unbranded cosmetic products – perfume, cream, lotion and shampoo – with a fragrance oil vial and botanicals
Unbranded cosmetic products – perfume, cream, lotion and shampoo – with a fragrance oil vial and botanicals

What is the CPR?

The Cos­me­tic Pro­ducts Regu­la­tion (Regu­la­tion (EC) No 1223⁄2009), adop­ted in 2009 and appli­ca­ble sin­ce 2013, is the Euro­pean Union’s sin­gle legal fra­me­work for cos­me­tic pro­ducts, buil­ding on a legis­la­ti­ve fra­me­work that dates back to as early as the 1970s. It sets out the rules that every cos­me­tic pro­duct must meet to be pla­ced on the EU mar­ket, from ingre­dient res­tric­tions and safety assess­ment to labe­ling and mar­ket surveillance.

Why the CPR matters for fragrance

For the fra­gran­ce sec­tor, the CPR is the regu­la­tion that most directly deter­mi­nes which ingre­dients can be used in a fra­gran­ce mix­tu­re sup­plied for cos­me­tic pro­ducts, and under what con­di­tions. Its Anne­xes list subs­tan­ces that are prohi­bi­ted, res­tric­ted or sub­ject to spe­ci­fi­ca­tions for use in cos­me­tic products.

For cer­tain fra­gran­ce ingre­dients clas­si­fied as car­ci­no­ge­nic, muta­ge­nic or toxic for repro­duc­tion (CMR), Arti­cle 15 of the CPR pro­vi­des a dero­ga­tion path­way for con­ti­nued use in cos­me­tics, whe­re safe use can be demons­tra­ted. The Scien­ti­fic Com­mit­tee on Con­su­mer Safety (SCCS) plays a cen­tral role throughout, pro­vi­ding the inde­pen­dent scien­ti­fic opi­nions that the­se deci­sions rely on. Becau­se a sin­gle fra­gran­ce can con­tain dozens, or even hun­dreds, of indi­vi­dual ingre­dients, how the CPR treats each ingre­dient has a direct impact on refor­mu­la­tion, inno­va­tion, and the sector’s abi­lity to keep brin­ging safe, high-qua­lity pro­ducts to Euro­pean consumers.

The Chemicals Omnibus (Omnibus VI), keeping safety at the core of the CPR

In 2026, EU co-legis­la­tors agreed the Che­mi­cals Omni­bus (Omni­bus VI), which intro­du­ces tar­ge­ted adjust­ments to the CPR. For fra­gran­ce, the most sig­ni­fi­cant chan­ge con­cerns the Arti­cle 15 dero­ga­tion pro­ce­du­re, which beco­mes a wor­ka­ble path­way for the con­ti­nued use of CMR-clas­si­fied ingre­dients that can be demons­tra­ted as safe. Omni­bus VI intro­du­ces clear dead­li­nes and transition periods, cla­ri­fies the approach for cons­ti­tuents of natu­ral com­plex subs­tan­ces, and the cri­te­ria for gran­ting a dero­ga­tion. The­se chan­ges address a mecha­nism that, in more than a deca­de under the CPR, had not resul­ted in a sin­gle dero­ga­tion being gran­ted des­pi­te seve­ral dos­sier sub­mis­sions. The SCCS retains its cen­tral role in asses­sing the safety of ingre­dients throughout this process.

Read more: EU Che­mi­cals Omni­bus (VI)

The evaluation of the CPR

The Euro­pean Com­mis­sion is currently carrying out an eva­lua­tion of the CPR, asses­sing its effec­ti­ve­ness, effi­ciency, rele­van­ce, cohe­ren­ce and EU added value sin­ce it star­ted to apply in 2013. IFRA is con­tri­bu­ting to this process.

IFRA con­si­ders the CPR one of the most com­prehen­si­ve and rigo­rous cos­me­tics regu­la­tions in the world, a fra­me­work that other juris­dic­tions fre­quently look to as a refe­ren­ce point. With the adjust­ments intro­du­ced through Omni­bus VI now agreed, IFRA belie­ves the CPR, once tho­se chan­ges take effect, will remain well pla­ced to meet its objec­ti­ves. Whether any further chan­ges pro­ve neces­sary is, in IFRA’s view, a ques­tion that deser­ves care­ful and con­ti­nued reflec­tion rather than a swift new legis­la­ti­ve revision.

IFRA also sup­ports the imple­men­ta­tion of the CPR as a mem­ber of the Euro­pean Commission’s Wor­king Group on Cos­me­tic Products.